These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 25770683)

  • 21. SAM domain-dependent activity of PfTKL3, an essential tyrosine kinase-like kinase of the human malaria parasite Plasmodium falciparum.
    Abdi A; Eschenlauer S; Reininger L; Doerig C
    Cell Mol Life Sci; 2010 Oct; 67(19):3355-69. PubMed ID: 20582613
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bioinformatic analysis of glycogen synthase kinase 3: human versus parasite kinases.
    Osolodkin DI; Zakharevich NV; Palyulin VA; Danilenko VN; Zefirov NS
    Parasitology; 2011 May; 138(6):725-35. PubMed ID: 21349219
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of hypusine biosynthesis in plasmodium: a possible, new strategy in prevention and therapy of malaria.
    Kaiser A; Ulmer D; Goebel T; Holzgrabe U; Saeftel M; Hoerauf A
    Mini Rev Med Chem; 2006 Nov; 6(11):1231-41. PubMed ID: 17100634
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasmodial Kinase Inhibitors: License to Cure?
    Cabrera DG; Horatscheck A; Wilson CR; Basarab G; Eyermann CJ; Chibale K
    J Med Chem; 2018 Sep; 61(18):8061-8077. PubMed ID: 29771541
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drugging the Plasmodium kinome: the benefits of academia-industry synergy.
    Leroy D; Doerig C
    Trends Pharmacol Sci; 2008 May; 29(5):241-9. PubMed ID: 18394721
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Repurposing apoptosis-inducing cancer drugs to treat schistosomiasis.
    Lee EF; Fairlie WD
    Future Med Chem; 2015; 7(6):707-11. PubMed ID: 25996064
    [No Abstract]   [Full Text] [Related]  

  • 27. Targeting malaria with specific CDK inhibitors.
    Geyer JA; Prigge ST; Waters NC
    Biochim Biophys Acta; 2005 Dec; 1754(1-2):160-70. PubMed ID: 16185941
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Functional studies of Plasmodium falciparum dipeptidyl aminopeptidase I using small molecule inhibitors and active site probes.
    Deu E; Leyva MJ; Albrow VE; Rice MJ; Ellman JA; Bogyo M
    Chem Biol; 2010 Aug; 17(8):808-19. PubMed ID: 20797610
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protein tyrosine kinases as new potential targets against human schistosomiasis.
    Dissous C; Ahier A; Khayath N
    Bioessays; 2007 Dec; 29(12):1281-8. PubMed ID: 18022808
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selective inhibitors of Plasmodium falciparum glycogen synthase-3 (PfGSK-3): New antimalarial agents?
    Masch A; Kunick C
    Biochim Biophys Acta; 2015 Oct; 1854(10 Pt B):1644-9. PubMed ID: 25861860
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lysine Deacetylase Inhibitors in Parasites: Past, Present, and Future Perspectives.
    Hailu GS; Robaa D; Forgione M; Sippl W; Rotili D; Mai A
    J Med Chem; 2017 Jun; 60(12):4780-4804. PubMed ID: 28241112
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potent bicyclic inhibitors of malarial cGMP-dependent protein kinase: approaches to combining improvements in cell potency, selectivity and structural novelty.
    Large JM; Birchall K; Bouloc NS; Merritt AT; Smiljanic-Hurley E; Tsagris DJ; Wheldon MC; Ansell KH; Coombs PJ; Kettleborough CA; Whalley D; Stewart LB; Bowyer PW; Baker DA; Osborne SA
    Bioorg Med Chem Lett; 2019 Oct; 29(19):126610. PubMed ID: 31471167
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Medicinal chemistry optimization of antiplasmodial imidazopyridazine hits from high throughput screening of a SoftFocus kinase library: part 1.
    Le Manach C; Gonzàlez Cabrera D; Douelle F; Nchinda AT; Younis Y; Taylor D; Wiesner L; White KL; Ryan E; March C; Duffy S; Avery VM; Waterson D; Witty MJ; Wittlin S; Charman SA; Street LJ; Chibale K
    J Med Chem; 2014 Mar; 57(6):2789-98. PubMed ID: 24568587
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Coinfection with Plasmodium falciparum and schistosoma haematobium: protective effect of schistosomiasis on malaria in senegalese children?
    Briand V; Watier L; LE Hesran JY; Garcia A; Cot M
    Am J Trop Med Hyg; 2005 Jun; 72(6):702-7. PubMed ID: 15964953
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New trends in chemotherapy on human and animal blood parasites.
    Schrével J; Millerioux V; Sinou V; Frappier F; Santus R; Grellier P
    Parasitol Res; 1996; 82(3):283-4. PubMed ID: 8801568
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting protein kinases in the malaria parasite: update of an antimalarial drug target.
    Zhang VM; Chavchich M; Waters NC
    Curr Top Med Chem; 2012; 12(5):456-72. PubMed ID: 22242850
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Algorithmic Mapping and Characterization of the Drug-Induced Phenotypic-Response Space of Parasites Causing Schistosomiasis.
    Singh R; Beasley R; Long T; Caffrey CR
    IEEE/ACM Trans Comput Biol Bioinform; 2018; 15(2):469-481. PubMed ID: 27071187
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Double-drug development against antioxidant enzymes from Plasmodium falciparum.
    Biot C; Dessolin J; Grellier P; Davioud-Charvet E
    Redox Rep; 2003; 8(5):280-3. PubMed ID: 14962365
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Subtle morbidities associated with malaria co-infection with schistosomiasis among children in South-West Nigeria.
    Oladele VS; Awobode HO; Anumudu CI
    Afr J Med Med Sci; 2014 Dec; 43 Suppl():125-35. PubMed ID: 26949790
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Trends in the development of chemotherapy for parasitic diseases.
    Arnold K
    Southeast Asian J Trop Med Public Health; 1978 Jun; 9(2):177-85. PubMed ID: 364672
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.